W Advisors, LLC Pfizer Inc Transaction History

W Advisors, LLC

$161 Million
Q3 2024

A detailed history of W Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, W Advisors, LLC holds 12,507 shares of PFE stock, worth $320,804. This represents 0.22% of its overall portfolio holdings.

Number of Shares

12,507

Previous 12,338 1.37%

Holding current value

$320,804

Previous $345,000 4.64%

% of portfolio

0.22%

Previous 0.23%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$27.7 - $31.39 $4,681 - $5,304	169 Added 1.37%	12,507 $361,000
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $7,527 - $8,820	298 Added 2.48%	12,338 $345,000
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $1,941 - $2,229	75 Added 0.63%	12,040 $334,000
Q4 2023 Feb 06, 2024	BUY	$26.13 - $33.94 $39,534 - $51,351	1,513 Added 14.48%	11,965 $344,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $27,629 - $32,296	-861 Reduced 7.61%	10,452 $346,000
Q2 2023 Aug 03, 2023	SELL	$36.12 - $41.79 $15,712 - $18,178	-435 Reduced 3.7%	11,313 $414,000
Q1 2023 Aug 07, 2023	SELL	$39.39 - $51.28 $3,860 - $5,025	-98 Reduced 0.87%	11,215 $457,000
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $3,465 - $4,523	83 Added 0.71%	11,748 $602,000
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $350 - $427	-8 Reduced 0.07%	11,665 $511,000
Q2 2022 Aug 26, 2022	BUY	$46.53 - $55.17 $4,932 - $5,848	106 Added 0.92%	11,673 $612,000
Q1 2022 Aug 26, 2022	BUY	$45.75 - $56.69 $34,770 - $43,084	760 Added 7.03%	11,567 $598,000
Q4 2021 Aug 15, 2022	BUY	$41.32 - $61.25 $446,545 - $661,928	10,807 New	10,807 $638,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on W Advisors, LLC with notifications on news.

Account